NEW YORK (GenomeWeb) – Premaitha Health announced today that it has signed a deal making GeNext the exclusive distributor of its Iona non-invasive prenatal screening test in Russia.

The Iona test estimates the risk of a fetus being affected by Down syndrome and other serious genetic conditions by analyzing cell-free fetal DNA from a maternal blood sample. It received CE marking about a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.